Innovative Healthcare Institute

Directions Website Contact the business

Innovative Healthcare Institute Connecting healthcare professionals through conferences, webinars, continuing medical education, and scientific publishing. Collaborate. Disseminate. Innovate.

Explore IHCI events and resources at innovativehci.com.

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐈𝐇𝐂𝐈: 𝐖𝐡𝐞𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐂𝐨𝐦𝐞 𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫Healthcare advances when knowledge is shared.At...
10/16/2026

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐈𝐇𝐂𝐈: 𝐖𝐡𝐞𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐂𝐨𝐦𝐞 𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫
Healthcare advances when knowledge is shared.

At the Innovative Healthcare Institute (IHCI), we support the exchange of scientific research, clinical expertise, and educational opportunities that help healthcare professionals stay informed, connected, and engaged.

Our work brings together three complementary initiatives:

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐉𝐨𝐮𝐫𝐧𝐚𝐥𝐬
A collection of seven scientific and medical journals supporting research, scholarly publication, and the exchange of knowledge across healthcare disciplines.

𝐈𝐧𝐧𝐨𝐒𝐜𝐡𝐨𝐥𝐚𝐫
A digital education platform that extends learning beyond traditional conferences and publications, connecting healthcare professionals with educational resources and opportunities for continued professional development.

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐍𝐞𝐭𝐰𝐨𝐫𝐤 (𝐈𝐎𝐍)
An initiative focused on connecting oncology professionals, encouraging collaboration, and supporting the exchange of clinical knowledge and perspectives.

Together, these initiatives reflect a shared commitment to advancing healthcare through research, education, and meaningful professional connections.

Whether you're a clinician, researcher, educator, or healthcare professional, 𝘵𝘩𝘦𝘳𝘦'𝘴 𝘢 𝘱𝘭𝘢𝘤𝘦 𝘧𝘰𝘳 𝘺𝘰𝘶 𝘪𝘯 𝘵𝘩𝘦 𝘐𝘏𝘊𝘐 𝘤𝘰𝘮𝘮𝘶𝘯𝘪𝘵𝘺.

Explore our initiatives and discover what's next:
https://innovativehci.com/

Follow IHCI for new research, educational opportunities, scientific publications, and upcoming programs.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡: 𝐁𝐞𝐲𝐨𝐧𝐝 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬, 𝐓𝐨𝐰𝐚𝐫𝐝 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬.Breast cancer awareness is important. But awareness is ...
10/15/2026

𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡: 𝐁𝐞𝐲𝐨𝐧𝐝 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬, 𝐓𝐨𝐰𝐚𝐫𝐝 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬.
Breast cancer awareness is important. But awareness is only the beginning.

Advances in cancer research continue to reshape how breast cancer is detected, understood, and treated. From molecular testing and targeted therapies to immunotherapy and increasingly personalized treatment approaches, scientific progress is creating new possibilities for patient care.

Yet important questions remain. How can we better predict treatment response? Reduce disparities in access to care? Translate emerging evidence into meaningful improvements in patient outcomes?

Progress depends on more than discovery. It requires collaboration among researchers, oncologists, multidisciplinary care teams, and the broader healthcare community.

This 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡, the Innovative Healthcare Institute (IHCI) recognizes the importance of continued research, clinical education, and knowledge sharing in advancing cancer care.

Because awareness starts the conversation. 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐦𝐨𝐯𝐞 𝐢𝐭 𝐟𝐨𝐫𝐰𝐚𝐫𝐝.

Explore IHCI: https://innovativehci.com/

10/15/2026

Thank you for joining us at Multiple Myeloma Crossroads!

Meaningful progress in cancer care depends on continued education, collaboration, and the exchange of clinical knowledge.

Thank you to the faculty, participants, and everyone who contributed to our October 14 educational program focused on multiple myeloma.

We appreciate the opportunity to bring healthcare professionals together to explore developments in the field and the questions shaping patient care.

Stay connected with the Innovative Healthcare Institute (IHCI) for upcoming educational programs, conferences, and opportunities to learn from experts across healthcare.

𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: 𝐎𝐧𝐞 𝐇𝐨𝐮𝐫. 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐬𝐞𝐬. 𝐄𝐱𝐩𝐞𝐫𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬.How are clinicians navigating first-line treatment decisions f...
10/13/2026

𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: 𝐎𝐧𝐞 𝐇𝐨𝐮𝐫. 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐬𝐞𝐬. 𝐄𝐱𝐩𝐞𝐫𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬.

How are clinicians navigating first-line treatment decisions for transplant-ineligible patients with multiple myeloma?

Join us Wednesday, October 14, from 6:30–7:30 PM ET for MM Crossroads & Perspectives™: Practical Expert Insights from Real-World Cases.

This interactive educational webinar will explore:
• Integrating anti-CD38 therapy into frontline treatment strategies
• Patient selection, frailty, and treatment considerations
• Real-world cases and clinical decision-making
• Live polling to compare practice patterns

Featuring expert faculty:
• Mohamed Hegazi, MD — UofL Health – Brown Cancer Center (Chair)
• Ahmad Mattour, MD — Henry Ford Health
• Jack Khouri, MD, FACP — Cleveland Clinic

Don't miss this opportunity to explore the clinical questions shaping multiple myeloma care.

Register today: https://innovativehci.com/event/mm-crossroads-2026/

For U.S.-based healthcare providers only.

This Wednesday: real-world cases, expert perspectives and your questions.Join us for MM Crossroads & Perspectives, a liv...
10/12/2026

This Wednesday: real-world cases, expert perspectives and your questions.

Join us for MM Crossroads & Perspectives, a live discussion on integrating anti-CD38 therapy into first-line treatment for transplant-ineligible patients with multiple myeloma.

Explore treatment decisions through a case presentation, live audience polling, faculty discussion and Q&A.

Featuring:
• Mohamed Hegazi, MD | UofL Health – Brown Cancer Center — Program Chair
• Ahmad Mattour, MD | Henry Ford Health
• Jack Khouri, MD | Cleveland Clinic

Wednesday, October 14 | 6:30–7:30 p.m. ET
Live virtual webinar for U.S.-based healthcare providers only.

Two days away—view the agenda and register:
https://innovativehci.com/event/mm-crossroads-2026/

How are clinicians integrating anti-CD38 therapy into first-line treatment for transplant-ineligible patients with multi...
10/09/2026

How are clinicians integrating anti-CD38 therapy into first-line treatment for transplant-ineligible patients with multiple myeloma?

𝐉𝐨𝐢𝐧 𝐉𝐚𝐜𝐤 𝐊𝐡𝐨𝐮𝐫𝐢, 𝐌𝐃, 𝐨𝐟 𝐂𝐥𝐞𝐯𝐞𝐥𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜, 𝐟𝐨𝐫 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐝𝐮𝐫𝐢𝐧𝐠 𝐌𝐌 𝐂𝐫𝐨𝐬𝐬𝐫𝐨𝐚𝐝𝐬 & 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬.

Dr. Khouri joins program chair Mohamed Hegazi, MD, of UofL Health – Brown Cancer Center, and Ahmad Mattour, MD, of Henry Ford Health, for a real-world case presentation, live polling, panel discussion and audience Q&A.

𝐅𝐢𝐯𝐞 𝐝𝐚𝐲𝐬 𝐚𝐰𝐚𝐲: Wednesday, October 14 | 6:30–7:30 p.m. ET

Live virtual webinar for U.S.-based healthcare providers only.

View the agenda and register:
https://innovativehci.com/event/mm-crossroads-2026/

𝐇𝐨𝐰 𝐰𝐨𝐮𝐥𝐝 𝐲𝐨𝐮 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐭𝐡𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧?On October 14, join MM Crossroads & Perspectives and participate in live a...
10/08/2026

𝐇𝐨𝐰 𝐰𝐨𝐮𝐥𝐝 𝐲𝐨𝐮 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐭𝐡𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧?

On October 14, join MM Crossroads & Perspectives and participate in live audience polling on transplant eligibility, treatment selection, and clinical challenges in multiple myeloma care.

Explore a real-world case and hear expert perspectives on integrating anti-CD38 therapy into first-line treatment for transplant-ineligible patients.

Bring your questions for the panel discussion and audience Q&A.

Featuring:
• Mohamed Hegazi, MD | UofL Health – Brown Cancer Center
• Ahmad Mattour, MD | Henry Ford Health
• Jack Khouri, MD | Cleveland Clinic

📅 Wednesday, October 14, 2026
🕡 6:30–7:30 p.m. ET
💻 Live virtual webinar for U.S.-based healthcare providers only

View the agenda and register:
https://innovativehci.com/event/mm-crossroads-2026/

A real-world case. A treatment decision. How would you approach it?Join MM Crossroads & Perspectives on October 14 for l...
10/07/2026

A real-world case. A treatment decision. How would you approach it?

Join MM Crossroads & Perspectives on October 14 for live polling on transplant eligibility, treatment selection, and clinical challenges in multiple myeloma care.

Explore the integration of anti-CD38 therapy into first-line treatment for transplant-ineligible patients with:

• Mohamed Hegazi, MD | UofL Health – Brown Cancer Center
• Ahmad Mattour, MD | Henry Ford Health
• Jack Khouri, MD | Cleveland Clinic

Bring your questions for the expert panel discussion and audience Q&A.

📅 October 14, 2026
🕡 6:30–7:30 p.m. ET
💻 Live virtual webinar for U.S.-based healthcare providers only

View the agenda and register:
https://innovativehci.com/event/mm-crossroads-2026/

10/07/2026

Article in JIPO on a smarter way to catch breast cancer treatment resistance early: in some hormone receptor-positive breast cancers, a blood test can detect a resistance-causing mutation (called ESR1) months before scans would show the cancer is growing again.

This piece discusses the SERENA-6 trial, which found that switching treatment as soon as this mutation is detected in the blood — rather than waiting for the cancer to visibly progress — can delay disease progression and help patients maintain their quality of life longer. The author cautions that more research is still needed before this becomes routine practice everywhere, but it's a promising step toward more personalized, proactive breast cancer care.

Read more: https://doi.org/10.36401/JIPO-26-5


OncoAlert Innovative Oncology Network Oncology Nursing Society King Abdulaziz University Atlal Abusanad

How do transplant eligibility and patient factors shape first-line treatment decisions in multiple myeloma?Join Ahmad Ma...
10/07/2026

How do transplant eligibility and patient factors shape first-line treatment decisions in multiple myeloma?

Join Ahmad Mattour, MD, of Henry Ford Health, for a real-world case presentation and live polling on transplant eligibility and treatment selection during MM Crossroads & Perspectives.

Dr. Mattour joins program chair Mohamed Hegazi, MD, of UofL Health – Brown Cancer Center, and Jack Khouri, MD, of Cleveland Clinic, for practical discussion on integrating anti-CD38 therapy into first-line treatment for transplant-ineligible patients with multiple myeloma.

📅 One week away: October 14
🕡 6:30–7:30 p.m. ET
💻 Live virtual webinar for U.S.-based healthcare providers only.

View the agenda and register:
https://innovativehci.com/event/mm-crossroads-2026/

Address

7100 Foundry Row Suite 288/90, Liberty Township
Cincinnati, OH
45069

Website

Alerts

Be the first to know and let us send you an email when Innovative Healthcare Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Innovative Healthcare Institute:

Shortcuts

Share

Category